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Abstract
Reproducibility, or a lack thereof, is an increasingly important topic across many research fields. A key aspect of
reproducibility is accurate reporting of both experiments and the resulting data. Herein, we propose a reporting guideline
for mass spectrometry imaging (MSI). Previous standards have laid out guidelines sufficient to guarantee a certain quality of
reporting; however, they set a high bar and as a consequence can be exhaustive and broad, thus limiting uptake.
To help address this lack of uptake, we propose a reporting supplement—Minimum Information About a Mass
Spectrometry Imaging Experiment (MIAMSIE)—and its abbreviated reporting standard version, MSIcheck. MIAMSIE is
intended to improve author-driven reporting. It is intentionally not exhaustive, but is rather designed for extensibility and
could therefore eventually become analogous to existing standards that aim to guarantee reporting quality. Conversely, its
abbreviated form MSIcheck is intended as a diagnostic tool focused on key aspects in MSI reporting.
We discuss how existing standards influenced MIAMSIE/MSIcheck and how these new approaches could positively impact
reporting quality, followed by test implementation of both standards to demonstrate their use. For MIAMSIE, we report on
author reviews of four articles and a dataset. For MSIcheck, we show a snapshot review of a one-month subset of the MSI
literature that indicated issues with data provision and the reporting of both data analysis steps and calibration settings for
MS systems. Although our contribution is MSI specific, we believe the underlying approach could be considered as a general
strategy for improving scientific reporting.
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Background
Our specific research field—mass spectrometry imaging (MSI)
[1]—applies mass spectrometry (MS) for the raster-based collec-
tion of mass spectra from a discrete set of locations on the sur-
face of a two-dimensional sample. This can be achieved for syn-
thetic (human-made materials) and natural (geological) surfaces
or, as is more common, biological cross-sections of plant and an-
imal tissues. Depending on sample preservation, preparation,
and MS settings, MSI can investigate the spatial distributions
for a wide variety of analytes, including small molecules (drugs,
lipids) [2], N-glycans [3] or peptides, and proteins [4]. MSI mea-
sures the molecular composition of a sample, simultaneously
acquiring information on hundreds to thousands of compounds,
in some cases, across multiple compound classes, without pre-
requisite knowledge of composition and without compound-
specific labeling (e.g., antibodies) [5]. The spatial component of
the information obtained by MSI is orthogonal to most omics ap-
proaches, which generally do not consider the spatial aspect of
global abundance changes [6].
It is in the MSI context that we address the current lack of
standardization in reported research. MSI is arguably one of the
most challenging experimental approaches in MS and, similar to
other MS-based technologies, is data intensive. Combined with
the numerous approaches available for sample preparation and
analysis, the care required during sample preparation [7], as well
as the observation that dedicated training is necessary to mas-
ter it [8], there is a need for highly detailed reporting. However,
adherence to the available reporting standards is not the norm,
and MSI requires a substantial step toward standardized accept-
able levels of reporting. This is important for building confidence
in the reproducibility of experimental results, both for method
development and in primary research. The importance of this is-
sue is exemplified by the so-called reproducibility crisis, which
is currently being widely discussed in the wider literature and
is not MSI specific [9]. One of the core concepts affecting repro-
ducibility is insufficient quality checks and reporting at both the
experimental and data processing levels [10]. These are the gaps
that we propose to address.
Reproducibility and the current reporting standards
Publication remains the primary method for result dissemina-
tion in the sciences. Transparency, accuracy, and completeness
in these reports form a cornerstone of reproducibility. Unfortu-
nately, even though the “crisis” is topical, discussions on ad-
dressing it are hampered by the fact that reproducibility is typ-
ically not well defined [11]. We propose to adopt the three-part
lexicon of Goodman et al. [11] in order to help clarify this am-
biguity. These three parts are methods, results, and inferential
reproducibility. We focus on the first two of these in our discus-
sion. Briefly, methods reproducibility is the ability to reproduce
the exact data analysis and arrive at identical end results. For ex-
ample, a publication would be methods reproducible if, using the
same analysis methods on the same raw data, one could arrive
at the same outputs (i.e., figures) as those reported in that publi-
cation. There is a degree of subjectivity in the choice of what re-
sults are presented in a figure. However, once that decision has
been made, the reproduction of that figure from the raw data
should be completely deterministic, and all the details required
for reproduction should be included in the publication/report.
In contrast, results reproducibility is the ability of other groups
to follow the reported procedures as closely as practical, generate
new data, and arrive at similar results. This requires that suffi-
cient detail be reported about these procedures and spans sam-
ple preparation, data acquisition, the data itself, as well as its
processing and analysis [11].
To achieve methods and results reproducibility [11], report-
ing in publications must obviously meet a certain quality stan-
dard. One might expect a minimum quality based on the sci-
entific method—scientists are driven to methodically replicate,
validate, and report their findings—that, combined with journal
guidelines [12] and the availability of alternate publication for-
mats such as protocols (Rapid Communications in Mass Spectrom-
etry), data briefs (Data-in-Brief), and video journals (Journal of Vi-
sualised Experiments), would suggest that all the pieces needed
for high-quality reporting are in place. Despite this resource-
rich environment, there are remaining issues in reporting. Ex-
isting standards such as the Minimum Information About a Pro-
teomics Experiment (MIAPE) [13] guidelines were added in an ef-
fort to prompt tangible improvements in reporting: to set the bar
by defining peer expectations of reporting and therefore, hope-
fully, have a tangible impact on reproducibility. There are several
other existing standards that are also MSI relevant and aim to
encompass different research communities. One of the broadest
is the minimum information for biological and biomedical in-
vestigations guidelines [14], which provide a framework of stan-
dards for the integrated reporting (i.e., reducing standards over-
lap) of biological experiments. MIAPE is a relevant standard spe-
cific to proteomics [13], and Minimum Information Required for
a Glycomics Experiment (MIRAGE) is similar but designed for gly-
comics [15]. MIAPE is compartmentalized further to include, e.g.,
MIAPE-MS [16], which is the most MSI-relevant component of
MIAPE. MIRAGE has also expanded to encompass sample prepa-
ration [17], MS analysis [15], and glycan microarray analysis [18].
These standards specify a minimum level of reporting quality by
identifying a set of information that should be included when
reporting an experiment and that is sufficient to guarantee that
the report will meet that specified level of quality.
One way to determine if research is being reported well
would be to evaluate its methods reproducibility. Obviously,
evaluating results reproducibility is the ideal, but it is expensive
and difficult to justify replication studies [19, 20]. Conversely,
confirming methods reproducibility is not easy in practice but
ultimately should at least be possible, if not also straightfor-
ward. While such confirmation does not directly evaluate re-
search quality, it does evaluate reporting quality. This is im-
portant enough that we suggest that it can be used as a cost-
effective heuristic to estimate results reproducibility and hence
“quality.” If we focus on methods reproducibility, it quickly be-
comes apparent that research is not being reported well. In ef-
fect, an individual could not repeat the study without further
input from the authors [20]. This is despite the existence of well-
defined standards and is a key component of the reproducibility
crisis. Crucially, this is not a reflection on the quality of existing
reporting standards, as they highlight core methods that require
reporting and raise valid discussion points. However, they are ei-
ther being misinterpreted—the assumption being that all scien-
tists will interpret a reporting requirement similarly—or simply
not being used. We suggest that an underlying cause of this is
that standards typically aim to set a bar for reporting quality far
above the current norm: they aim to be both necessary and suffi-
cient. In practice they end up being sufficient, but not necessary,
conditions for reporting quality.
Sufficiency vs necessity: sacrificing sufficiency for
practicality
To illustrate the concepts of necessary and sufficient condi-
tions for reporting quality, we describe the two fundamental
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sufficient and necessary. One approach would be to start with a
list of experimental details that, together, are sufficient but not
necessary. As many details as possible would then be removed
while maintaining sufficiency. Eventually, if the details are gran-
ular enough, the last superfluous detail would be removed, and
no other details could be removed while still maintaining suffi-
ciency. At this point, the standard would not only be sufficient
but also necessary to achieve the specified level of quality. This is
the approach the existing standards take. Conversely, one could
start from a blank slate—no experimental details—and add a
necessary detail, such as provision of raw data. This would now
be necessary, but not sufficient, for achieving the given level of
reporting quality. One could then continue to add necessary ex-
perimental details until sufficiency is reached. This is the ap-
proach we use with Minimum Information About a Mass Spec-
trometry Imaging Experiment (MIAMSIE). We are not setting a
fixed bar, but introducing a bar that can be steadily lifted as the
field adopts it. Note that although having a standard that is both
sufficient and necessary would be the best-case scenario, we are
not claiming that this is realistic. Rather, we claim that the ap-
proach of starting with a sufficient standard and iterating from
there has not produced the intended improvements in the field.
Taking a different approach, such as starting from a necessary
standard and iterating in the other direction, could potentially
produce more tangible improvements in reporting quality as it
would produce intermediate steps that are easier to implement.
The requirement for sufficiency in existing standards neces-
sitates broad, all-encompassing, and consequently ambiguous
phrasing. This can result in the unintentional omission of ex-
perimental detail(s). For example, in MIAPE-MS 2.98 [21], the
“Acquisition parameters” are required. The problem with broadly
phrased detail requests such as these is that they allow for
equally broad responses, such as “the default acquisition parame-
ters were used.” Here, an assumption might be that reporting de-
fault settings for a company-installed and therefore “standard”
system is sufficient to encompass “Acquisition parameters.” An-
other example from MIAMPE-MS 2.98 is that “Parameters used in
the generation of peak lists or processed spectra” are required. In this
example, if peak lists were generated by smoothing, baseline re-
duction, and peak picking, a description of only the smoothing
and peak-picking parameters would still technically satisfy “Pa-
rameters used in the generation of peak lists.” Unfortunately, such in-
consistencies are difficult to audit. The only way to conclusively
determine that the methods described are insufficient to repro-
duce an analysis would be to apply the methods to the raw data
and demonstrate different results. This is not standard practice
during peer review and, as we will demonstrate, is not realistic
given the lack of raw data provision in MSI. One goal of report-
ing should be to convince reviewers and the community that re-
production would be possible given time and resources, not to
complicate design or data such that reproduction is deemed im-
practical.
We stress at this point that our assumption is not that omis-
sion is intentional but that it results from the lack of clarity in
reporting standards, the lack of uptake, the complexity of con-
temporary experimental procedures, the “assumed knowledge”
afforded to some process steps, and the time pressure for pub-
lication. In the absence of automated data and meta-data har-
vesting [22], a human-driven reporting standard could compen-
sate for human error by directly prompting the inclusion of as
many necessary experimental details as possible [15]. Further-
more, such granular standards that directly prompt inclusion
of very specific information also allow for auditing of existing
reports with relative ease in comparison to the existing broad
standards for which this would be relatively difficult. Easy au-
diting could be of interest to authors, reviewers, journals, or any
other individual or organization for whom systematic reporting
quality control is key. Standards that allow auditing with relative
ease could also be translated to in-house record-keeping pro-
cesses, thereby not only reducing the time required for trans-
lation of research notes to publication format but also making
inter-laboratory comparisons, quality control, and standardiza-
tion consistent and practical.
A two-part approach to granular MSI reporting
standards
Misinterpretation of standards due to broad and vague phrasing
can be minimized by creating more granular standards, in which
the required information is defined more explicitly [23]. As a side
effect, an increase in specificity may also lead to greater ease of
use and therefore greater reporting compliance [24]. However,
granular and explicit terms make it unrealistic to be broad and
all-encompassing, at least initially before such standards have
had time to evolve as the research community interacts with
them. Because of this, any initial proposed standard will pref-
erentially favor a certain subset of methods and experimental
designs. It should be noted that we, and others before us, do
not intend for granularity to subsequently imply the preferred
use of particular methods or experimental designs; we aim to
address structured reporting only [15, 25]. We also claim that
progressive standards iteration and collaboration should pro-
duce improvements that will incrementally remove any such
researcher-driven bias, as the standards gradually evolve to be-
come more broad and all-encompassing while also reflecting the
true method and design biases present in the MSI field.
Granular items of necessary detail are exemplified by the re-
cent suggestion to include negative controls for analyte delocal-
ization in MSI [26]. This would involve the inclusion of off-tissue
spectra in every MSI data acquisition region. The suggestion is
a good one and necessary to evaluate sample preparation qual-
ity. However, it is narrow in scope and, alone, it is far from suf-
ficiency. At the other end of the spectrum, the MIRAGE guide-
lines are a good example of a complete granular standard—to
the point of having an explicit list of fields to be filled in. This
typifies the prompting concept and is a consequence of the spe-
cific requirements of glycomics, as related to the complexity of
glycans and their fragility during MS analysis [15].
A granular standard was proposed for MSI in 2012 on the
Mass Spectrometry Imaging Society (MSIS) forum [27]. Unfortu-
nately, the MSI community did not seem to engage with this
initiative. The last contribution was in June 2012 and is cur-
rently not accessible. McDonnell et al. continued the discussion
in 2015 by suggesting a working document for an updated granu-
lar MSI extension of MIAPE [23]. The suggested standard focused
on the “minimum information that is necessary to adequately
describe an MSI experiment”—i.e., it aims to be both necessary
and sufficient [23]. Additional recommendations, as also sug-
gested by sources that include MIAPE and MIRAGE, were that
a standard should be able to grow with the field (i.e., be stable
and modular)—and balance completeness of reporting (adding
reporting details) with practicality, or operational uptake [13, 15,
23]. Although potentially less powerful, a practical and, there-
fore, minimalist standard makes implementation easier. This
approach may be the driver needed for tangible reporting im-
provements. Since then, there has been a need to continue the
reporting standards discussion initiated by the MSIS and prompt
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In this context, we propose a template of reporting fields, MI-
AMSIE, that directly prompts the collection of very specific gran-
ular information, reminiscent of a methods section that lists
materials and processes, rather than providing this as prose.
This allows not only straightforward completion but also rapid
quantitative evaluation of adherence to the standard when col-
lected in a standardized format. Collating this information is
a Herculean task for published studies that follow a sufficient
guideline but provide this information as unstructured prose.
Given that current sufficient standards suffer from low up-
take rates, we also propose that MIAMSIE should initially be ab-
breviated to prioritize uptake over completeness: a brevity-with-
impact concept. The abbreviated reporting template was named
MSIcheck. As is to be expected, both the full and abbreviated
versions are suited for different tasks. MIAMSIE is an author-
driven reporting aid intended to prompt the user into provid-
ing a number of key pieces of granular information [15], repre-
sented as a list of fields that are important for reporting an MSI
experiment. MIAMSIE is designed for expansion, to adapt to user
needs so as to gradually become more comprehensive over time.
To demonstrate the concept proposed, we have focused on laser
desorption/ionization (LDI)-specific MSI. However, the intent is
for community engagement to drive expansion to encompass
the entirety of the field. The key is to ensure that the ultimate
aim of sufficiency in a mature MSI standard is not lost. In effect,
the current version of MIAMSIE does not aim to guarantee re-
porting quality but is intended as a step toward this guarantee.
MSIcheck makes implementation as easy as possible. It is impor-
tant to note that it is not a separate standard but rather a subset
of MIAMSIE that is designed to be very easy to use in order to
achieve more rapid impact. Instead of setting the bar for report-
ing quality, MSIcheck focuses on absolute key aspects of a report
in order to evaluate the current state of the field and identify
problem points that need to be prioritized. As we outline herein,
the aim is for the fields in MSIcheck to grow along with uptake,
thereby initially prioritizing uptake over impact, with the ulti-
mate end goal being a MIAMSIE standard that encompasses the
entire MSI field.
Here, we discuss the genesis, structure, and scope of MI-
AMSIE and the abbreviated reporting template MSIcheck, the
improvement we anticipate will be brought to the field, and
the results of implementing both to reporting of publications
and datasets (MIAMSIE) and for review of the MSI literature
(MSIcheck).
MIAMSIE
The purpose and scope of MIAMSIE
MIAMSIE (Supplementary Table S1) is a conglomerate list of ex-
perimental reporting fields that directly draws upon and con-
solidates several existing resources in MS. The core standard is
based on the MIAPE imaging export template provided in the R
package Cardinal [28, 29], as well as consideration of the report-
ing requirements of MIAPE [13] and specifically the MIAPE-MS
module [16], the MSI data standard imzML [30], and the MSI stan-
dard proposed by McDonnell et al. in 2015 [23]. In addition, field
names and descriptions are either verbatim, as in contributing
standards such as MIAPE imaging, or modified based on the re-
quirements of the conglomerate MIAMSIE standard.
Note that the intent of MIAMSIE is not to provide a com-
plete, field-wide, reporting template and mechanism that will
gold-plate adherence to a standard. If the concept is popular,
MIAMSIE should evolve to encompass existing ontologies, the
requirements of varied experimental MSI niches, and a tool that
streamlines provision of these reports in a structured format
that can also be examined effectively by nonexperts. This is be-
yond the scope of the discussion presented here but is the ulti-
mate driver of this work.
The intended use of MIAMSIE is as a reporting supplement
for:
 Primary research articles, protocols, and data briefs;
 Registered reports describing an experiment [10], e.g., accom-
panying a submission to a data repository (PRoteomics IDEn-
tifications [PRIDE] [31]);
 Teaching of structured reporting (in-house or at work-
shops/conferences); and
 Regular day-to-day in-house record-keeping.
MIAMSIE currently focuses heavily on laser LDI-MSI and, in
particular, matrix-assisted laser desorption/ionization (MALDI)-
MSI. This is deliberate, as this is our main technology platform,
but also as we intend to demonstrate how such a standard could
be used to improve reporting. Obviously, this means the inclu-
sion of many MALDI-specific fields. The intention is that users
will add fields as they need them (e.g., secondary ion mass
spectrometry (SIMS)-specific fields), gradually making MIAMSIE
more comprehensive. A core philosophy of MIAMSIE is to be as
unambiguous as practical with regards to the type and amount
of information requested. As a result, the individual entries are
very granular. This granularity, combined with the focused scope
of the initial standard, mean that the standard does not cur-
rently guarantee a sufficient quality level for reporting across all
MSI studies. This will only be possible if the standard is used
and expanded, thereby gradually raising the bar. Assuming high
uptake, it is hoped that MIAMSIE, or a potential successor, will
eventually be able to guarantee a sufficient level of reporting
quality for MSI, in much the same way that existing standards
such as MIAPE intend. MIAMSIE aims to provide standardized re-
porting and also encourage further discussion and development
(i.e., tools for reporting).
Terminology used in the MIAMSIE standard
The terminology used in MIAMSIE is intended to minimize am-
biguity; however, there are key terms that are left necessarily
broad due to the variety of experiments that MIAMSIE is in-
tended to capture. These include experiment, sample, and dataset.
An experiment includes experimental design, hypotheses and
aims, the entire collection of samples used, the sample prepa-
ration, the datasets that have been collected, as well as the data
analysis used. Essentially, the term experiment is used to describe
the entire study that MIAMSIE is being used to document and is
often directly related to a publication. A sample refers to the sur-
face to which MSI is applied and can be from a synthetic, nat-
ural, or biological source. Often an experiment will collect data
from several samples with different sources. These samples may
differ either internally or from each other or may originate from
different categories (biological/clinical) that are directly relevant
to the hypotheses. A dataset refers to a single acquisition area or
region on a sample from which a collection of spectra have been
acquired. Typically, these spectra will have been collected using
virtually identical acquisition parameters across all samples.
The reason it is important to leave sample and dataset rela-
tively broad is that there exist MIAMSIE fields that will require
different values for different experiment types. As a result, the
terms sample and dataset need to label these experiments in a
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different values will naturally differ across experiment types.
For example, in an experiment where a murine kidney is sec-
tioned and analyzed by MSI and a subset of sections are treated
with an enzyme to release N-glycans [32], samples could be de-
fined as “enzyme treated” or “control.” This allows for the sam-
ple preparation steps to be assigned either of these two values
for each sample, with each identified by the appropriate sample
name, thereby unambiguously defining which sections of tissue
were treated with what preparation procedure while still being
as concise as possible. To use an additional example, if the laser
power or some other data acquisition parameter was optimized
for each section, then the sections could be defined as separate
datasets, each with a unique identifying dataset name, and the
laser power for each one would be identified using these names.
Datasets would then be linked to samples, i.e., which datasets
are in which samples and vice versa. Essentially, the intention
is for samples and datasets to provide useful partitions of the
data into subsets that differ in sample preparation, origin, or
data acquisition parameters. The exact way in which the data
are partitioned will differ in any given experiment, and so the
user should be mindful of defining these terms in the context of
the experiment clearly and carefully and should be consistent
with their definitions. As an additional example, these defini-
tions can be included as part of the Value(s) for the Sample and
Dataset fields or be defined in the publication with appropriate
reference to the MIAMSIE field in question.
The structure of MIAMSIE
The initial premise was that to satisfy MIAMSIE, a value needed
to be provided for every field. However, during development, it
became clear that a large number of fields are only required
conditionally. In effect, they depend on the answer to a “gating
question” such as “Was LDI used for ionization?” To continue
with this example, if the answer is “Yes,” values for all the LDI-
dependent fields need to be provided, and if the answer is “No,”
these fields are not applicable. To help navigate MIAMSIE, con-
ditional fields were grouped as much as possible and the list an-
notated with the relevant gating questions.
Each individual field in the template (Supplementary Table
S1) has an ID (a unique identifier), a Name (a short name for
the field), a Description (a more detailed explanation of the in-
formation requested by the field), a Category (useful for organiz-
ing information), a list of Valid Values for the field, and an empty
column where a Value could be provided for a given field and
experiment. These valid values improve MIAMSIE’s usability by
providing guidance on completion of the required fields. In the
Description for a field, it may reference another field in the format
#(AAA) where # is the ID for the field being referenced and AAA
is its Name. If a field is not relevant to a particular experiment, a
value of NA is accepted and is indicated at the beginning of the
Valid Values characteristic for that field. This identifies the con-
ditional fields mentioned above, and the purpose of the gating
questions is essentially to identify the fields that can be ignored
(given a value of NA). Some fields only have a limited number
of possible values, in which case they are listed in the Valid Val-
ues characteristic for that field. Other fields have valid values not
listed in Valid Values, and these are identified by the entry ending
with an ellipsis (. . . ).
Each field in MIAMSIE belongs to one of five possible cate-
gories (see Fig. 1): General, Sample Preparation, MSI Data, Process-
ing, and Other. Of these categories, General contains fields that
provide links to additional information, experiment-wide de-
tails (Aim, Hypothesis), identifying names for datasets and sam-
Figure 1: Schematic overview of categories and example fields from MIAMSIE
and how the complete list of fields was abbreviated to form the more succinct
MSIcheck standard.
ples (Dataset Names & Sample List), and fields providing informa-
tion about how datasets and samples are related (Sample Disam-
biguation). Fields in the General category are broadly applicable
and could therefore serve as a starting point when adapting MI-
AMSIE to another scientific field. In contrast, the Other category
provides a field for information that is specific to a particular
experiment but for which a field is not provided in MIAMSIE. Ex-
amples include results validation by orthogonal MS or non-MSI
methods (e.g., nuclear magnetic resonance). This provides a key
functionality for MIAMSIE, allowing adopters to incrementally
raise the bar for reporting quality by adding information when
deemed necessary for a specific report without specifically re-
quiring an additional mechanism (e.g., online tool or graphical
user interface [GUI]). As MIAMSIE evolves and fields are added,
we would expect the Other category to see less use, and its over-
use could provide information on fields or entire MSI workflows
that should be added. Intermediate categories Sample Prepara-
tion, MSI Data, and Processing contain many fields that could have
different values for different datasets or samples and so may
require the provision of multiple values. Ideally, the final itera-
tion of this standard will use a GUI that, in addition to allowing
easy recording of MIAMSIE information, will also include mech-
anisms for suggesting new fields. An alternative approach that
could prompt open discourse regarding the content of the stan-
dard would be to host the current working MIAMSIE document
on a resource such as GitHub [33], allowing monitoring, sugges-
tions for changes, as well as forum discussions to be transparent
and have greater reach. As MIAMSIE is informed by imzML, this
approach could also encompass tools such as mzML2ISA, which
streamlines reporting of fields that appear in mzML and imzML
controlled vocabularies [22].
MIAMSIE as a conditional hierarchy
To illustrate the way in which we anticipate that MIAMSIE will
evolve with peer contribution, we briefly describe its iterative
development pre-publication. Prior to its finalization, a draft list
of the MIAMSIE fields was provided to our co-authors for a test
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plementary Tables S2 and S3) and one in-house dataset (Sup-
plementary Table S4). As completed for these experiments, MI-
AMSIE was able to cover experimental details of interest while
also allowing an overview of the study scope and processes. The
template nature of the standard prompted inclusion of the re-
quested information and was therefore straightforward to im-
plement. However, MIAMSIE was still considered lengthy and
thus potentially difficult to complete. Suggestions for improve-
ment included clarification of the information being requested
by individual fields, the addition of other MSI modalities, in-
creasing the relevance of the provided fields to more MSI study
types, and improving the ease of completion.
In line with these discussions between the authors, several
changes were made to MIAMSIE while maintaining its core con-
tent, including
 The gating questions were added to create an improved tem-
plate user interface. In effect, when the answer “Yes” is se-
lected for a gating question, the MIAMSIE fields relevant to
that question become visible, otherwise they are hidden.
This ensures that, as much as practical, only relevant fields
need to be considered, significantly simplifying completion
of the standard and directly addressing the perceived diffi-
culty of using MIAMSIE.
 The first additional ionization technique-specific fields were
added: SIMS (e.g., ToF Nano).
 Fields were added to improve the relevance of the standard
across a more diverse array of MSI experiments. This in-
cluded extra conditionally gated fields for botanical, natural
(geological), and synthetic samples, as well as making the
storage and sample treatment fields more flexible. This re-
flected the varied analytical backgrounds of the authors.
 Fields that were important to a study but not strictly nec-
essary for complete reporting of an experiment itself were
removed (e.g., Ethics Approval, Abstract).
 The Descriptions and/or Valid Values for some fields were clar-
ified, as necessary.
With these modifications, the final MIAMSIE template (Sup-
plementary Table S1) contains a total of 130 fields. This is re-
duced to 81 fields with the updated user interface, assuming
a single MSI acquisition with MALDI is completed for a stabi-
lized cross-section of a biological sample that is also visualized
(hematoxylin & eosin [H&E] or microscopy), with only the raw
data provided (no processing or MSI visualization). As condi-
tional answers change (e.g., ± storage or in situ chemistries, pro-
cessing), the number of fields that need to be filled in by the user
would change accordingly.
The observation that MIAMSIE needed streamlining to in-
crease uptake was expected, but the contrast between perceived
and actual difficulty of completion was stark. Although it con-
tains more than 100 fields, one co-author estimated their com-
pletion at less than 20 minutes. This is a reasonable time frame
for completion of MIAMSIE by the principal researcher(s), par-
ticularly when balanced against the amount of information be-
ing recorded. A detail-focused standard such as MIAMSIE is only
feasible as a reporting scheme for authors, as they will be suf-
ficiently familiar with their experiments to make the process
practical. Nevertheless, this perception, which is likely to per-
sist regardless, means it is unlikely that MIAMSIE alone will
gain the traction required to meaningfully improve reporting
across the MSI field. We suggest that widespread uptake will
require a parallel intermediate option that can produce grad-
ual improvements. Below, we suggest an abbreviated reporting
standard called MSIcheck for this role. Other steps might in-
clude automated harvesting of the information requested by MI-
AMSIE and/or other standards [15]. This is possible for a sig-
nificant subset of MIAMSIE but would require vendor support
to achieve. Regardless of the discussion provided here, future
work in this space should engage vendors, MSIS [27], as well
as repositories (e.g., PRIDE [31] and metaspace2020 [34]) and
journals.
The aim should be to introduce a successor standard that
aggregates a clearly defined granular standard such as MIAM-
SIE with the requirements across the MSI field (McDonnell et al.,
MIAPE, imzML), achieves this by building on existing ontologies,
and achieves measurable uptake by initially defining a more con-
servative and straightforward reporting expectation.
MSIcheck
Brevity with impact
We believe that practical tools that support incremental change
are effective mechanisms that can improve reporting and re-
producibility [25]. This was the core motivation for creating
MSIcheck: an abbreviated reporting template, based on MIAM-
SIE, that focuses on fields that we believe represent common
problem points. The implication is that if these are addressed,
a demonstrable and relatively rapid improvement to the field
would result. The 32 MIAMSIE fields that comprise MSIcheck are
presented in Fig. 2. Supplementary Table S5 provides the MIAM-
SIE ID number, Name, and Description for each reporting field. No-
tice that gating questions have been removed in a further effort
to create a minimalist report format. The brevity of MSIcheck
means it is easier to complete than the full MIAMSIE standard
and, as a result, it has a greater number of practical applications.
For example, MSIcheck can be used for editorial or peer reviews
(similar to the Life Sciences Reporting Summary required for
submission to Nature or the Minimum Standards of Reporting
Checklist required for submission to GigaScience) or for post-hoc
reviews of literature publications. MIAMSIE would be unsuitable
for the majority of these use cases.
MSIcheck can also provide a quantitative insight into the
state of reporting quality field wide, following application to
a significant subset of the published MSI literature. This is
achieved by ensuring standardized data entry for MSIcheck
fields in a readily accessible file format (e.g., ASCII) that sub-
sequently allows import, transformation, and presentation of
the data using open-source platforms (e.g., R [29]). Naturally, ap-
plying it to the entire MSI literature is unrealistic and beyond
the scope of this work, and so here we applied MSIcheck to
a one-month snapshot from 2017. This approach could regu-
larly capture the state-of-the-field with respect to the direction
and composition of MSI in a more transparent way than anony-
mous surveys [35] but also highlight progress made in address-
ing key perceived issues in MSI. These issues include, but are
not limited to, data provision and the complete reporting of both
software versions and processing pipelines. If used on a regu-
lar basis for a large enough portion of the literature, MSIcheck
could track uptake over time and inform its own further devel-
opment by presenting quantifiable metrics (see Fig. 3) that in-
dicate which fields are poorly reported and should become fo-
cal points for improvement. Beneficial consequences of this may
include the gradual uptake and growth of MSIcheck to become
a complete standard (MIAMSIE), an annual publication review-
ing the state of MSI, and the creation of a culture in which ad-
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Figure 2: MSIcheck standard with the corresponding MIAMSIE field Names.
Figure 3: Counts for each MSIcheck field, indicating the number of articles (of 19) for which the field information was or was not provided (Yes/No), was Limited (more
information required), or was not applicable to the article (N/A). Figure generated using R [29, 57-59]. See Additional Files (Element S8) for R script details.
Application of MSIcheck
With MSIcheck defined, we applied it to a review of two example
studies from the laboratory of the last author (P.H.) as well as a
retrospective review of the literature.
Similar to journal checklists, MSIcheck allows for rapid
nonexhaustive publication assessment. Application here to two
specific previous publications [36, 37] (Supplementary Table S6)
highlighted that MSIcheck can be completed in less than 10
minutes, with time noted as the most important factor. Sec-
ondary, but still important, was the inclusion of MSIcheck for
journal article reviewers. MSIcheck was considered comprehen-
sive enough in a technical sense, as most, if not all, technical in-
formation of immediate import is there. Not unexpectedly, there
was also interest in the subjective inclusion of other MIAMSIE
fields in MSIcheck, e.g., including the Hypothesis of a study or
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MSIcheck more time consuming to complete, our experience is
that a first author−driven MIAMSIE review can be achieved in
less than 20 minutes.
For the literature MSIcheck, all articles discoverable in
PubMed using the search terms maldi and imaging were selected
for the month of June (2017). Manual evaluation of these 31 doc-
uments resulted in a final list of 19 primary MSI research ar-
ticles that were readily accessible (i.e., not behind a paywall)
and excluded reviews, protocols, and opinion pieces. The full
list of articles and their inclusion status is provided in Supple-
mentary Table S7. The 19 articles selected were reviewed using
MSIcheck [38-56]. To avoid assessing the quality of the underly-
ing science, which is not the intended purpose of MSIcheck, the
review was limited to the abstract, materials and methods, as
well as the supplementary information, as this can often con-
tain an extended methods sections. The focus was ultimately
if the information required by each field was included, rather
than on the information itself. As such, the fields were placed
into one of four categories summarizing the degree to which the
information was included in the paper. These categories were
“Yes” (the information was provided), “No” (the information was
not provided), “Limited” (the information was partially provided
but more detail was required), and “Not Applicable” (the field was
deemed to be not relevant, e.g., a direct MSI analysis paper may
not use an in situ chemistry, or in situ MS/MS may not have been
required). An assumption made here is that subjective evalua-
tion of the importance of providing some information vs some
information not being applicable (N/A) will not greatly impact
the final assessment of the publications reviewed. It is not pos-
sible, even with curation, to perfectly address the subjective in-
terpretation of whether a study has provided only limited in-
formation for a particular field or has provided the information
requested. In short, a perfect post-hoc assessment is difficult to
achieve; however, as much care as practical was taken during
review. The potential for misinterpretation of what fields are re-
quired or not applicable is a strong argument for standardiza-
tion. If a field is needed, it will be completed in the standard;
there is reduced ambiguity in filling out a community-accepted
granular reporting schema. Note also that some of the current
MSIcheck fields would normally require sample or dataset dis-
ambiguation; they may have different values for different sub-
sets of the data, and this would need to be noted. As the focus
of MSIcheck was to evaluate if the information required was in-
cluded in the paper or not, these multiple values could conve-
niently be collapsed into a single value for each field; either the
information was provided for all subsets of the data (a value of
“Yes”) or it was provided for some subsets of the data and not
others (a value of “Limited”).
An overview of the retrospective MSIcheck results are pre-
sented in Fig. 3, as a count of the Yes, No, Limited, and N/A re-
sponses. There are multiple noteworthy conclusions to be drawn
from this output. These are discussed in more detail in the fol-
lowing sections.
General observations from the one-month MSI review
There were noteworthy trends apparent from the MSIcheck
summary in Fig. 3. First, several fields were reported well, includ-
ing many Sample Preparation and MSI Data category fields such as
Analyzer, Ionization, and Matrix. The fields that were consistently
not well reported included Scan, Laser Diameter, as well as Cal
Type, Cal Standard, Control Version, and Process Version. Scan reso-
lution determines the accuracy of optical alignment to sample
stage position prior to MSI data acquisition and consequently
impacts the quality of surface region selection for MSI. Laser di-
ameter impacts not only the spatial resolution of MSI but the
appropriate use of oversampling. Oversampling can be inferred
if both spatial resolution and laser diameter are reported; this is
not the norm. The poor reporting of calibration is typically con-
fined to those studies that employ MS instruments that decouple
ionization and mass analysis (fourier transform mass spectrom-
etry, FTMS). These instruments do not always require calibra-
tion prior to each measurement, and as such, this information
is easily overlooked. Finally, MS control and MSI processing soft-
ware version were not well reported. This impacts methods re-
producibility, particularly as many software packages are read-
ily updated or patched, which can alter how they perform pro-
cessing or analysis steps. To use the example of FTMS, the latest
versions of ftmsControl (solarix instruments) enable filtering for
significant data reduction and also remove artifacts introduced
by the signal processing (i.e., Fourier transform). Such steps need
crystal-clear definition, as they impact what is being considered
the “raw” output of an MS platform prior to any user process-
ing and analysis. While this is complicated by the proprietary
nature of some hardware and software, the broad-strokes defi-
nition of all data acquisition and preprocessing steps should be
available. If not, where are these details being recorded and how
can the appropriateness of these processes be critiqued either
now or in the future? This question is growing more relevant as
subscription-based sales models for analysis software become
more common. If software can be updated or altered without
the user being able to return to a prior version, methods repro-
ducibility becomes even harder to achieve.
Observations that relate to day-to-day implementation be-
came obvious following the MSIcheck literature review. First,
there are fields for which the high N/A count supports the mod-
ification of MSIcheck to remove these fields. A good example is
that not many of the publications modified their surfaces (Sur-
face Mods). As suggested above, a further review of a much larger
number of articles (6 months–1 year) could allow modification
of MSIcheck, based on the quantitative assessment resulting
from such a review (see Fig. 3). The impact of a regular bird’s-
eye view of MSI reporting is difficult to predict. However, we an-
ticipate that this information will provide an incentive to be a
visible contributor to improving the field [20]. We certainly want
to demonstrate a commitment to scientific rigor and allow for
more informed decisions regarding the design and content of a
community-derived high-impact reporting standard.
Finally, the initial MSIcheck review was performed by two
of the authors. A comparison of these independent reviews re-
vealed some inconsistencies in the responses. Qualitatively, the
reviews had a high degree of overlap, and this was mirrored in
the focused review (Supplementary Table S6). The observation
that not all answers were similar highlights that even with a
prompting review system, results still need to be curated, as is
the case with repositories such as PRIDE [60].
“Show us the data”
Providing raw data allows other researchers to reproduce results,
apply methods or conclusions in subsequent studies, improve
on workflows, and make comparisons with existing studies [11,
61]. Often, the only way to validate methods reproducibility is to
apply reported methods to the raw data. The immediate issue is
that none of the articles reviewed by MSIcheck provide direct ac-
cess to raw data; this observation was mirrored in the MIAMSIE
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Using MSIcheck as is, there are two caveats that may indi-
cate that data availability was overlooked. First, data links could
have been included in obscure or unreviewed locations or could
have been made available as separate links by the journal or pub-
lisher. Links should be provided in a prominent and highly visi-
ble location, both in the article and online. The Data Availability
Statement that appears in a side bar on the first page of articles
published by PLOS ONE is a good example of such a prominent
location. Second, raw data submission to a repository may have
been delayed until after publication. In this scenario, the data re-
source would obviously not be cited in the preceding publication
but would exist as its own citable resource.
Assuming the review is correct, its results contrast with the
trend of increased data sharing in other MS-specific fields such
as proteomics [62]. From a practical standpoint, the fact that raw
data makes it easier to discover novel phenomena, draw alterna-
tive conclusions, and correct mistakes is secondary to incentives
and ease of data provision [20, 63]. Current incentives should
outweigh apprehensions surrounding re-use, and ease of data
provision will only increase as both infrastructure and the pro-
cesses supporting streamlined and efficient data provision and
analysis are developed further [64, 65].
Apprehension surrounding data provision may stem from
the discovery of errors, which impacts reputation, or the po-
tential loss of future publications. First, although embarrass-
ing, mistakes and analytical errors do happen and should be
corrected quickly. Rather than stoking fears, raw data provision
supports the contention that discovery of conflicting findings is
welcomed, that any mistakes are honest, and ultimately that au-
thors value their legacy in the literature [66].
Second, it is possible that novel or noteworthy findings can
be identified through the re-use of data; this is but another av-
enue toward the cumulative gain of knowledge [64, 65]. In fact,
bleeding-edge research relies on repository data. Development
of MSI data analysis methods, e.g., uses such data to compare
the results of novel methods against published results using the
same data. Unfortunately, most independent groups do not have
the time or resources for further in-depth analysis of reposi-
tory datasets, particularly due to the need for specialist infor-
maticians for “big-data” mining (e.g., multi-omics, systems biol-
ogy). This is championed by consortia (e.g., the Human Proteome
Project [67], European Molecular Biology Laboratory [EMBL] [68])
and may thus explain the 88% (of >2M total) of data citation in-
dex (DCI) entries on Web of Science that are uncited, despite the
bulk of DCI entries representing the “hard” sciences, including
PRIDE entries [69-71]. Nevertheless, more than 160 TB of data
were downloaded from PRIDE in 2014 [72]. To put this in con-
text, the total size of PRIDE reached 100 TB in 2015 [62]. MSI data
generation alone was estimated at >1 TB/day globally in 2015
[35]. Thus, in general, MS datasets are being re-used, but the
scope of this re-use globally is still small. The idea that other
groups are waiting to “poach” these datasets is not realistic or
productive. In combination with data citations (or digital object
identifiers, DOIs [72]), which make datasets citable objects in the
literature, re-use should not be an issue. This is supported by the
original laboratories being best placed to re-analyze their data in
context and considering that the current publish-or-perish cul-
ture devalues re-analysis and reproduction [20]. Ultimately, until
data provision becomes the MSI standard, the pragmatist’s ap-
proach is to make re-use possible in principle by providing raw
data in order to emphasize the importance of data citation and
to focus first on achievable analyses and spearhead subsequent
re-analyses in collaboration with colleagues in complementary
fields.
Apprehensions aside, ease of completion/provision and in-
centives [20] are big determinants of data provision [20, 63].
Fortunately, there are solutions in place or under development
that standardize and incentivize MSI data sharing. This includes
suitable repositories, as MSI generates data of significant size
(>100 GB for FTMS) and in unique spatially referenced formats.
Raw MSI data-sharing was made feasible both by the introduc-
tion of a shared community data format, imzML [30], as well as
the modification of the PRIDE repository in 2015 to accept both
imzML and vendor formats [73]. This was significant as PRIDE
can support and curate large datasets, maintain privacy of the
data until manuscript acceptance, and is part of the ProteomeX-
change consortium, which integrates MS data from multiple
repositories [62]. Although this is a concrete step in the right
direction, as of 5 February 2018, the PRIDE repository only con-
tained nine datasets of experiment-type MSI. PRIDE seems un-
derutilized, which may suggest issues surrounding data upload.
This absence may also be explained by more active engagement
with the Metabolights repository [74] that, like PRIDE, is hosted
by EMBL-European Bioinformatics Institute. This resource has
become a popular alternative; 326 datasets were available using
the search term “mass spectrometry imaging” and filtering for
“study” (10 July 2018). This result is perhaps not surprising given
the skew in MSI toward metabolite imaging.
Equally important to the availability of repositories is the in-
centive to upload. In this context, MSI data availability is also
being addressed by additional consortia such as Metaspace2020
[35, 75] and software providers such as SCiLS (SCiLS Cloud [76]).
Similar to PRIDE, Metaspace supports large dataset uploads for
high mass resolution MSI data (typically FTMS), directly through
a drag-and-drop web interface. However, it is currently a re-
source with a fundamentally different purpose to PRIDE. Metas-
pace processes, annotates [75], and presents MSI data (see sum-
mary [34]) but does not provide access to the raw data. There
is therefore a strong incentive for data upload, as researchers
can easily benefit from access to an MSI-specific annotation tool.
PRIDE was only modified to allow partial MSI upload and does
not generate MSI DOIs [72], supported by a large consortium of
academia (e.g., EMBL) and industry (e.g., MS vendors, journals),
while only sharing the processed MSI output data in the form of
ion intensity maps. The combination of simple interface, access
to annotation tools, and removal of apprehensions surrounding
raw data provision may explain the rapid uptake of Metaspace,
which grew from 1,433 (5 July 2017) to 2,249 (29 January 2018)
complete datasets in the space of approximately seven months.
This is in contrast to the 4,657 publicly discoverable datasets on
PRIDE (29 January 2018), of which 9 were MSI. Metaspace has
therefore exhibited a growth rate (∼136 datasets/month) simi-
lar to that of PRIDE in 2015 (average of 150 datasets/month) [72].
The MSI community should strive to achieve raw data provision
rates similar to that seen for Metaspace. The future possibility of
authors permitting raw data download from Metaspace should
not be discounted, nor should PRIDE, which can accept MSI data,
has extensibility to allow the provision of additional reporting
attributes (MIAMSIE) from controlled vocabularies [31] and may
one day offer complete MSI submissions that are completely in-
tegrated with PX/PRIDE workflows [64, 65].
With the indexation of data in repositories (DCI), citability
of data objects (DOIs), continuing development of repository in-
frastructure and tools, as well as the expectation of data pro-
vision by journals, funding bodies, and major institutions, data
sharing is becoming an inescapable but ultimately win-win situ-
ation [64]. The underlying principle is that if it is easier for other
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cite your data and publications more often [65], increase their in-
dividual impacts, and improve your h-index. In line with these
findings, and assuming the case for raw data provision in MSI
can be supported by monitoring (MSIcheck), it would be benefi-
cial to examine the re-use rates and citation metrics for random
selections of primary MSI articles that do and do not provide ac-
cess to raw data; the expectation being that raw data provides a
citation advantage [77].
Conclusions
At the core of healthy peer-reviewed scientific literature is the
ability to both critique and build upon the work of other re-
searchers. In order for that to be possible, methods, results, and
data must be reported to a standard that allows for them to be
reproduced and hence for their significance in the wider con-
text of the field to be given its appropriate weight. Here, we have
presented our contribution to the discussion regarding a report-
ing standard for MSI. MIAMSIE provides content and a suggested
format that could eventually, with field-wide discussion and de-
velopment, become a standard sufficient to guarantee reporting
quality, in the same spirit as MIRAGE and the granular MSI stan-
dard suggested by McDonnell [23]. MSIcheck concedes the diffi-
culty in promoting uptake by providing an easy-to-complete ab-
breviated reporting standard that can be used in different ways
to improve not only reporting of experiments but also aid in peer
review, literature reviews, and the establishment of reporting
reputation as a tangible incentive to stimulate engagement of all
MSI researchers with community-endorsed reporting standards.
As demonstrated by MSIcheck, true raw data availability has
yet to become a stage-gate for MSI reporting. In addition, there
appear to be significant improvements to be made in reporting
of both analysis/processing steps and for MS-specific calibra-
tion metrics. This is an unfortunate status quo. We believe true
change will be underpinned by our capacity to measure, report
on, and promote the provision of data across the entire MSI field,
in line with efforts across the sciences to create an open data
culture. Finally, it is imperative for groups that excel in report-
ing to drive the development of tools that simplify the reporting
of our increasingly complex experiments and to show the way
by implementing these tools in conjunction with both reposito-
ries and publishers. Ultimately, standards such as MIAMSIE are
useful despite the lack of data provision in the field, particularly
as diagnostics and for in-house record keeping. Time will tell how
useful the described approach will be and how well it will trans-
late to improvements in reporting and reproducibility for MSI.
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